May 17, 2022
Kim Iversen reacts to Stephen Colbert’s Covid diagnosis. The U.S. Food and Drug Administration issued an EUA for the emergency use of Paxlovid for the treatment of mild-to-moderate coronavirus disease 2019 (COVID-19) in adults and pediatric patients with positive results of direct severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral testing, and who are at high risk for progression to severe COVID-19, including hospitalization or death. The 5-day treatment course of PAXLOVID should be initiated as soon as possible after a diagnosis of COVID-19 has been made, and within 5 days of symptom onset. Should a patient require hospitalization due to severe or critical COVID-19 after starting treatment with PAXLOVID, the patient should complete the full 5-day treatment course per the healthcare provider’s discretion. According to clinical trial data, Paxlovid had an 89% reduction in the risk of hospitalization and death. The CDC says the risk for covid increases steadily as you age, and it’s not just those over the age of 65 who are at increased risk for severe illness.